Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes

NCT07254572 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
PreDiabetes

Interventions

DRUG: Semaglutide 14 MG [Rybelsus]
DRUG: Dapagliflozin (Forxiga)
DRUG: Metformin
BEHAVIORAL: Optimal Medical Therapy (OMT) And Lifestyle Intervention

Sponsor

National Institute of Cardiology, Warsaw, Poland

Collaborators

[object Object]